Clearbridge Health Limited has entered into business collaboration with MILS International for the exclusive distribution of MILS's diagnostic tests in 11 countries. The two-year collaboration will allow Clearbridge to distribute MILS's full range of tests in Singapore, India, Indonesia, Malaysia, the Philippines, Korea, Taiwan, Thailand, Vietnam, Australia and Hong Kong. It was the first to apply human body fluid metabolites analysis by Gas Chromatography­-Mass Spectrometry. By processing urine samples, MILS's laboratory can provide reports to guide individuals to start taking preventive health measures and address disorders that can result in early mortality or lifelong disability. Its tests include screening for Inborn Errors of Metabolism and also assessing the healthy functioning of glucose metabolism.